Yarbrough Capital, LLC Dexcom Inc Transaction History
Yarbrough Capital, LLC
- $2.4 Billion
- Q2 2024
A detailed history of Yarbrough Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Yarbrough Capital, LLC holds 11,725 shares of DXCM stock, worth $785,809. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,725
Previous 11,725
-0.0%
Holding current value
$785,809
Previous $1.63 Million
18.27%
% of portfolio
0.06%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding DXCM
# of Institutions
1,113Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.12 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.31 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.09 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.03 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$801 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...